Search Results for "Herpes Foto"

18:06 EST 14th February 2016 | BioPortfolio

Matching Channels

Matching News

FOTO Partners with Practice Perfect

KNOXVILLE, TN -- FOTO announced Sept. 1 a partnership with Practice Perfect, whereby users can send information about new patients directly from Practice Perfect to FOTO, enabling cost and time saving...

FOTO Announces New Integration Partnership with Practice Perfect

Knoxville, TN (PRWEB) September 01, 2015 The integration of Practice Perfect and FOTO will allow users to send information about new...

FOTO Partners with Clinicient on Outcomes System

PORTLAND, OR -- Clinicient Inc. announced Nov. 10 a technological collaboration with Focus On Therapeutic Outcomes Inc. (FOTO®), a medical rehabilitation company that measures and reports functio...

FOTO Named Partner of Physical Therapy Outcomes Registry

KNOXVILLE, TN -- FOTO announced Sept. 3 its partnership with the Physical Therapy Outcomes Registry, an organized system for collecting data to evaluate patient function and other clinically relevant ...

FOTO’s Outcomes Reporting System Integrates With Clinicient’s Insight Platform

Knoxville, TN (PRWEB) November 10, 2015 Clinicient Inc., a leader in outpatient rehabilitation automation solutions, today announced...

Globally, an estimated two-thirds of the population under 50 are infected with herpes simplex virus type 1

More than 3.7 billion people under the age of 50 – or 67% of the population – are infected with herpes simplex virus type 1 (HSV-1), according to WHO’s first global estimates of HSV-1 infection...

Two-thirds of people under 50 have herpes: WHO

More than 3.7 billion people under 50 have the highly-infectious and incurable

GSK provides update on Herpevac trial for women evaluating Simplirix™ (Herpes Simplex Vaccine)

GlaxoSmithKline (GSK) has made the decision not to pursue further worldwide development of Simplirix™ (Herpes Simplex Vaccine), an experimental vaccine intended to prevent genital herpes disease...

Matching PubMed Articles

Calcium spirulan derived from Spirulina platensis inhibits herpes simplex virus 1 attachment to human keratinocytes and protects against herpes labialis.

Chronic infections with herpes simplex virus (HSV) type 1 are highly prevalent in populations worldwide and cause recurrent oral lesions in up to 40% of infected subjects.

Typical case: herpes zoster.

The varicella zoster virus is the causative agent of herpes zoster and varicella. In herpes zoster, the virus dormant within dorsal root ganglia is reactivated, resulting in painful vesicular lesions ...

Herpes Zoster Duplex Bilateralis in Immuno-Competent Patients: Report of Two Cases.

Herpes Zoster is a common viral disorder, occurs due to reactivation of latent Varicella Zoster Virus (VZV) usually in adults or elderly patients, usually confined to a single dermatome. Herpes zoster...

Interventions for prevention of herpes simplex labialis (cold sores on the lips).

Herpes simplex labialis (HSL), also known as cold sores, is a common disease of the lips caused by the herpes simplex virus, which is found throughout the world. It presents as a painful vesicular eru...

A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model.

A clinical vaccine that protects from ocular herpes simplex virus type 1 (HSV-1) infection and disease still is lacking. In the present study, preclinical vaccine trials of nine asymptomatic (ASYMP) p...

Search Whole site using Google

Quick Search
Advertisement Advertisement